非裔美国人2型糖尿病相关终末期肾病的全外显子组关联研究
该研究对456例非裔美国人2型糖尿病相关终末期肾病(T2D-ESKD)患者和936例非糖尿病非肾病对照进行外显子测序,并在2020例病例和1121例对照中验证,Meta分析共4533例样本。发现8个位点的11个提示性关联,排除APOL1风险基因型后另发现3个位点,RREB1的rs41302867与T2D-ESKD及非糖尿病ESKD均相关(OR=0.47,P=1.2×10⁻⁶)。
要点
- 外显子组关联分析在非裔美国人中识别出多个与T2D-ESKD相关的编码变异。
- RREB1 rs41302867与T2D-ESKD及非糖尿病ESKD均显示一致关联(OR=0.47)。
- 排除APOL1风险基因型后仍发现OTUD7B、IFITM3、DLGAP5等新位点。
核心结论
- 编码遗传变异可能参与非裔美国人2型糖尿病相关终末期肾病的易感性。
研究设计与样本
- 发现阶段对456例非裔美国人T2D-ESKD病例和936例非糖尿病非肾病对照进行外显子测序,采用混合逻辑回归关联分析。
- 验证阶段在额外2020例T2D-ESKD病例和1121例非糖尿病非肾病对照中复制名义关联(P<0.05)。
- Meta分析合并发现与验证阶段共4533例样本,并在额外1910例非糖尿病ESKD、219例T2D-ESKD及912例对照中测试推定关联。
主要发现
- Meta分析显示8个位点(PLEKHN1、NADK、RAD51AP2、RREB1、PEX6、GRM8、PRX、APOL1)共11个提示性T2D-ESKD关联(P<1×10⁻⁴)。
- 排除APOL1肾风险基因型携带者后,识别出3个额外提示性位点(OTUD7B、IFITM3、DLGAP5)。
- RREB1的rs41302867与T2D-ESKD及非糖尿病ESKD均显示一致关联(OR=0.47;P=1.2×10⁻⁶,4605例全因ESKD和2969例非糖尿病非肾病对照)。
临床怎么用
- RREB1 rs41302867等编码变异可能作为非裔美国人T2D-ESKD风险分层的候选标记,但需进一步验证。
局限性
- 原文未明确报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Compared with European Americans, African Americans (AAs) are at higher risk for developing end-stage kidney disease (ESKD). Genome-wide association studies (GWAS) have identified >70 genetic variants associated with kidney function and chronic kidney disease (CKD) in patients with and without diabetes. However, these variants explain a small proportion of disease liability. This study examined the contribution of coding genetic variants for risk of type 2 diabetes (T2D)-attributed ESKD and advanced CKD in AAs. METHODS: Exome sequencing was performed in 456 AA T2D-ESKD cases, and 936 AA nondiabetic, non-nephropathy control individuals at the discovery stage. A mixed logistic regression model was used for association analysis. Nominal associations (P < 0.05) were replicated in an additional 2020 T2D-ESKD cases and 1121 nondiabetic, non-nephropathy control individuals. A meta-analysis combining 4533 discovery and replication samples was performed. Putative T2D-ESKD associations were tested in additional 1910 nondiabetic ESKD and 219 T2D-ESKD cases, as well as 912 AA nondiabetic non-nephropathy control individuals. RESULTS: A total of 11 suggestive T2D-ESKD associations (P < 1 x 10-4) from 8 loci (PLEKHN1, NADK, RAD51AP2, RREB1, PEX6, GRM8, PRX, APOL1) were apparent in the meta-analysis. Exclusion of APOL1 renal-risk genotype carriers identified 3 additional suggestive loci (OTUD7B, IFITM3, DLGAP5). Rs41302867 in RREB1 displayed consistent association with T2D-ESKD and nondiabetic ESKD (odds ratio: 0.47; P = 1.2 x 10-6 in 4605 all-cause ESKD and 2969 nondiabetic non-nephropathy control individuals). CONCLUSION: Our findings suggest that coding genetic variants are implicated in predisposition to T2D-ESKD in AAs.
引用
- Guan M, Keaton JM, Dimitrov L, et al. An Exome-wide Association Study for Type 2 Diabetes-Attributed End-Stage Kidney Disease in African Americans. Kidney Int Rep. 2018. PMID: 29989002. doi:10.1016/j.ekir.2018.03.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。